E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/24/2006 in the Prospect News Biotech Daily.

Minrad plans follow-on for 10 million shares via Oppenheimer, KeyBanc, Maxim

By Ronda Fears

Memphis, April 24 - Minrad International, Inc. plans to sell 10 million shares in a follow-on offering via bookrunner Oppenheimer & Co.

KeyBanc Capital Markets and Maxim Group LLC are co-managers.

There is a greenshoe of 1.5 million shares available.

At a price of $3.31 per share, net proceeds are estimated at $30.6 million, or $35.3 million with the greenshoe.

Minrad shares (Amex: BUF) closed Monday higher by 24 cents, or 7.36%, at $3.50.

Buffalo, N.Y.-based Minrad, which focuses on pain management products, plans to use proceeds to expand its Bethlehem facility and capital investment in a new Orchard Park, N.Y., headquarters, the development of new products and to pay down the outstanding balance of $3.1 million under a credit facility with KeyBank.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.